Velocity Clinical Research • Grants Pass

02/10/2025

The future of clinical trials, now available in the palm of your hand. Meet VISION Engage!

This app empowers you to easily match with new study opportunities, earn rewards, and turn connections into cash. Don’t wait! Download the app today at https://buff.ly/3QDRI1x!

View full app terms and conditions at https://buff.ly/3QbPRzo

02/05/2025

Discover the latest breakthroughs in potential treatments for asthma in our new article. Learn about triggers, advancements, and Velocity's commitment to clinical trials. Ready to breathe in the latest updates? Check it out now!

Explore the latest in asthma research, including potential treatments and innovative solutions, even those currently in clinical trials.

02/01/2025

Thank you to the doctors, nurses, coordinators, clinicians, and participants of color at the forefront of clinical research. Without the knowledge and expertise of Black clinical research professionals, and the willingness of Black patients to participate in clinical trials, it would not be possible to develop new treatments, vaccines, devices, and cures to diseases for diverse communities. We see you and we celebrate you.

01/31/2025

Meet VISION Engage! Download the official Velocity app to get matched with new studies, earn rewards, and help move science forward. Learn more and download the app:
https://velocityclinicaltrials.com/vision-engage-app/

View full app terms and conditions at

Get matched with clinical trial opportunities near you with Velocity's VISION Engage app. Download now on iOS and Android.

01/29/2025

Even if you haven’t heard of , you’ve likely been infected with it. Almost 90% of children are infected with RSV before they are two years old. Learn more about this highly contagious and potentially deadly virus, and what we're doing to fight it:

While there are several approved RSV vaccines, many more promising RSV vaccine candidates are currently in clinical trials.

01/28/2025

Melissa, a Velocity COVID-19 vaccine trial participant, explains why she joined the clinical trial, and describes her initial experiences in our Patient Story. Read it here:

Participant Story: Melissa, a Research Study Participant at Velocity. How did you first hear about Velocity?

01/12/2025

If only people could see what diabetic nerve pain feels like. A clinical research study is now recruiting adults living with painful diabetic peripheral neuropathy. Qualified participants will receive compensation for study-related time and reimbursement for travel. To learn more, talk to your doctor and visit buff.ly/3DwdSOU.

01/11/2025

Now Enrolling: COPD Research Study: Velocity is conducting a study for an investigational COPD medication for people age 40 and older. Chronic obstructive pulmonary disease (COPD) is a group of diseases that cause airflow blockage and breathing problems. Symptoms of COPD include coughing or wheezing, shortness of breath, trouble taking a deep breath, and excess phlegm. Call (541) 327-0323 or visit https://buff.ly/40dnAOZ

01/10/2025

If you're struggling with migraines, you may qualify for a new clinical trial. Talk to your parents and learn more here. (541) 327-0323 or visit https://buff.ly/40dnAOZ

01/09/2025

If you struggle with long-term pain in your legs due to diabetes, also known as diabetic peripheral neuropathy, the Navigator DPN 1 Study may be an option for you. This study is researching a non-opioid investigational drug, suzetrigine, as an alternative to existing medicines for pain management. To learn more, talk to your doctor and visit buff.ly/3DwdSOU today.

01/08/2025

You Have Options: Get info about this study for an investigational COPD medication. Chronic obstructive pulmonary disease (COPD) is a group of diseases that cause airflow blockage and breathing problems. Symptoms of COPD include coughing or wheezing, shortness of breath, trouble taking a deep breath, and excess phlegm. Call (541) 327-0323 or visit https://buff.ly/40dnAOZ

01/07/2025

FLAIR pediatric and adult asthma study: Learn more about the FLAIR pediatric and adult asthma study. This study is now enrolling participants 4 years of age or older with a diagnosis of asthma for at least 1 year, and who had at least 1 asthma attack in the past 12 months. Click to see study details. Now enrolling: Call (541) 237-0323 or visit https://buff.ly/40dnAOZ